{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:52:42Z","timestamp":1783774362857,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1053\/j.ajkd.2014.05.020","type":"journal-article","created":{"date-parts":[[2014,8,16]],"date-time":"2014-08-16T04:04:50Z","timestamp":1408161890000},"page":"592-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["ESRD From Autosomal Dominant Polycystic Kidney Disease in the United States, 2001-2010"],"prefix":"10.1053","volume":"64","author":[{"given":"Scott","family":"Reule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donal J.","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Solid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan J.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1053\/j.ajkd.2014.05.020_bib1","first-page":"e1","article-title":"US Renal Data System 2012 annual data report","volume":"61","author":"Collins","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2014.05.020_bib2","first-page":"1258","article-title":"Tolvaptan in autosomal dominant polycystic kidney disease","volume":"368","author":"Jouret","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2014.05.020_bib3","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2014.05.020_bib4","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1093\/ndt\/gfs264","article-title":"Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study","volume":"27","author":"Stallone","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2014.05.020_bib5","unstructured":"US Renal Data System. 2013 Researcher's guide to the USRDS database; appendix D: data file descriptions. http:\/\/www.usrds.org\/2013\/rg\/C_Data_File_Descriptions_13.pdf. Accessed May 20,\u00a02014."},{"key":"10.1053\/j.ajkd.2014.05.020_bib6","unstructured":"US Census Bureau. State intercensal estimates (2000-2010). 2013. https:\/\/www.census.gov\/popest\/data\/intercensal\/state\/state2010.html. Accessed May 20,\u00a02014."},{"key":"10.1053\/j.ajkd.2014.05.020_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","article-title":"Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality","volume":"38","author":"Perrone","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2014.05.020_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","article-title":"Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980","volume":"2","author":"Iglesias","year":"1983","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2014.05.020_bib9","first-page":"477","article-title":"Polycystic kidney disease re-evaluated: a population-based study","volume":"79","author":"Davies","year":"1991","journal-title":"Q\u00a0J Med"},{"key":"10.1053\/j.ajkd.2014.05.020_bib10","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/ndt\/gfg233","article-title":"Trends in the incidence of renal replacement therapy for end-stage renal disease\u00a0in Europe, 1990-1999","volume":"18","author":"Stengel","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2014.05.020_bib11","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/ndt\/gfh317","article-title":"Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause","volume":"19","author":"Wakai","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2014.05.020_bib12","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2215\/CJN.01460210","article-title":"Improved prognosis in patients with autosomal dominant polycystic\u00a0kidney disease in Denmark","volume":"5","author":"Orskov","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2014.05.020_bib13","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.ajkd.2011.01.023","article-title":"Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study","volume":"57","author":"Patch","year":"2011","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263861400972X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263861400972X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:22:23Z","timestamp":1759458143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263861400972X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S027263861400972X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.05.020","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESRD From Autosomal Dominant Polycystic Kidney Disease in the United States, 2001-2010","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}